Zura Bio Limited
ZURA
$4.75
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.53% | -19.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.68% | 8.07% | |||
| Operating Income | 5.68% | -8.07% | |||
| Income Before Tax | 4.79% | -12.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.79% | -12.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.79% | -12.80% | |||
| EBIT | 5.68% | -8.07% | |||
| EBITDA | 5.69% | -8.05% | |||
| EPS Basic | -128.36% | -24.94% | |||
| Normalized Basic EPS | 5.03% | -12.45% | |||
| EPS Diluted | -128.36% | -24.94% | |||
| Normalized Diluted EPS | 5.03% | -12.45% | |||
| Average Basic Shares Outstanding | 0.27% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.27% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||